首页> 外国专利> METHOD FOR EVALUATING OSTEOGENIC POTENTIAL OF MESENCHYMAL STROMAL CELLS

METHOD FOR EVALUATING OSTEOGENIC POTENTIAL OF MESENCHYMAL STROMAL CELLS

机译:骨髓间充质基质细胞骨形成潜能的评估方法

摘要

FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to biotechnology, and can be used to assess the osteogenic potential of mesenchymal stromal cells. This method includes an assessment of gene expression BGLAP Osteocalcin, BMPR1A, BMP1, IGF1, COL1A1, COL3A1, ALPL, RUNX2, SMAD2, SMAD4, VDR, FGF-2, IGFR1, SPP1 Osteopontin, TGFBR1 using the real-time PCR method. Considering changes of the expression, a change in the osteogenic potential of mesenchymal stromal cells is detected, and a criterion for osteogenic enhancement is an increase in the gene expression BGLAP Osteocalcin, BMP1, IGF-1, COL1A1, COL3A1, ALPL, RUNX2, SMAD2, SMAD4, VDR and decrease in the expression of low differentiation genes BMPR1A, FGF-2, IGFR1, SPP1 Osteopontin, TGFBR1 on the 20day of cultivation.EFFECT: use of this method allows to compare different cultures among themselves, as well as different passages of the same culture, which allows to choose the optimal cell cultures for use in medicine.1 cl, 1 tbl
机译:技术领域本发明涉及医学,即生物技术,并且可以用于评估间充质基质细胞的成骨潜能。该方法包括使用实时PCR方法评估BGLAP骨钙素,BMPR1A,BMP1,IGF1,COL1A1,COL3A1,ALPL,RUNX2,SMAD2,SMAD4,VDR,FGF-2,IGFR1,SPP1骨桥蛋白,TGFBR1的基因表达。考虑到表达的变化,检测到间充质基质细胞的成骨潜能变化,并且成骨增强的标准是基因表达增加BGLAP骨钙素,BMP1,IGF-1,COL1A1,COL3A1,ALPL,RUNX2,SMAD2 ,SMAD4,VDR和低分化基因BMPR1A,FGF-2,IGFR1,SPP1骨桥蛋白,TGFBR1的表达在培养20天后的效果:使用此方法可以比较不同培养物之间的不同培养以及不同传代相同的培养物,可以选择用于医学的最佳细胞培养物。1cl,1 tbl

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号